Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors

Details for Australian Patent Application No. 2004246791 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Alho, Sari; Johansson, Nina; Vihko, Kimmo; Huhtinen, Kaisa; Lilienkampf, Annamaria; Wahala, Kristiina; Koskimies, Pasi

Agent Watermark

Pub. Number AU-B-2004246791

PCT Pub. Number WO2004/110459

Priority 60/477,017 10.06.03 US

Filing date 9 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 18 February 2010

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 495/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/110459 Priority application(s): WO2004/110459

18 February 2010 Application Accepted

  Published as AU-B-2004246791

17 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004246800-2-aminopyrimidine derivatives as Raf kinase inhibitors

2004246783-Fungicidal mixtures based on a triazolopyrimidine derivative